Irbesartan in Patients with Heart Failure and Preserved Ejection FractionMASSIE, Barry M; CARSON, Peter E; PTASZYNSKA, Agata et al.The New England journal of medicine. 2008, Vol 359, Num 23, pp 2456-2467, issn 0028-4793, 12 p.Article

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failureWU, Audrey H; GHALI, Jalal K; NEUBERG, Gerald W et al.The American heart journal. 2010, Vol 160, Num 5, pp 928-933, issn 0002-8703, 6 p.Article

Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support : Results of the oral enoximone in intravenous inotrope-dependent subjects trialFELDMAN, Arthur M; OREN, Ron M; MATHIER, Michael A et al.The American heart journal. 2007, Vol 154, Num 5, pp 861-869, issn 0002-8703, 9 p.Article

Important Differences in Mode of Death Between Men and Women With Heart Failure Who Would Qualify for a Primary Prevention Implantable Cardioverter-DefibrillatorRHO, Robert W; PATTON, Kristen K; POOLE, Jeanne E et al.Circulation (New York, N.Y.). 2012, Vol 126, Num 20, pp 2402-2407, issn 0009-7322, 6 p.Article

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)MAGGIONI, Aldo P; LATINI, Roberto; CARSON, Peter E et al.The American heart journal. 2005, Vol 149, Num 3, pp 548-557, issn 0002-8703, 10 p.Article

Influence of Global Region on Outcomes in Heart Failure Beta-Blocker TrialsO'CONNOR, Christopher M; FIUZAT, Mona; SWEDBERG, Karl et al.Journal of the American College of Cardiology. 2011, Vol 58, Num 9, pp 915-922, issn 0735-1097, 8 p.Article

Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection FractionZILE, Michael R; GOTTDIENER, John S; HETZEL, Scott J et al.Circulation (New York, N.Y.). 2011, Vol 124, Num 23, pp 2491-2501, issn 0009-7322, 11 p.Article

The Safety of an Adenosine A₁-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment: Findings from PROTECTTEERLINK, John R; IRAGUI, Vicente J; ZILE, Michael R et al.Drug safety. 2012, Vol 35, Num 3, pp 233-244, issn 0114-5916, 12 p.Article

Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) TrialZILE, Michael R; GAASCH, William H; KOMAJDA, Michel et al.Circulation (New York, N.Y.). 2010, Vol 121, Num 12, pp 1393-1405, issn 0009-7322, 13 p.Article

Prediction of mode of death in heart failure : The seattle heart failure modelMOZAFFARIAN, Dariush; ANKER, Stefan D; POOLE-WILSON, Philip A et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 4, pp 392-398, issn 0009-7322, 7 p.Article

Diuretic resistance predicts mortality in patients with advanced heart failureNEUBERG, Gerald W; MILLER, Alan B; PACKER, Milton et al.The American heart journal. 2002, Vol 144, Num 1, pp 31-38, issn 0002-8703Article